Josip Matić

Dr. Josip Matić

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2020 in AAPS PharmSciTech
Verified
Journal Article
Open access
PDF file
JMJosip Matić
Josip Matić
APAmrit Paudel
Amrit Paudel
HBHannes Bauer
Hannes Bauer
RGRaymar Andreina Lara Garcia
Raymar Andreina Lara Garcia
KBKinga Biedrzycka
Kinga Biedrzycka
Johannes KhinastJohannes Khinast
Johannes Khinast
This paper presents a rational workflow for developing enabling formulations, such as amorphous solid dispersions, via hot-melt extrusion in less than a year. First, our approach to an integrated product and process development framework is described, including state-of-the-art theoretical concepts, modeling, and experimental characterization described in the literature and developed by us. Next, lab-scale extruder setups are designed (processing conditions and screw design) based on a rational, model-based framework that takes into account the thermal load required, the mixing capabilities, and the thermo-mechanical degradation. The predicted optimal process setup can be validated quickly in the pilot plant. Lastly, a transfer of the process to any GMP-certified manufacturing site can be performed in silico for any extruder based on our validated computational framework. In summary, the proposed workflow massively reduces the risk in product and process development and shortens the drug-to-market time for enabling formulations.

6 January 2017 in AIChE Journal
Verified
Journal Article
Closed access
PDF file
AEAndreas Eitzlmayr
Andreas Eitzlmayr
JMJosip Matić
Josip Matić
Johannes KhinastJohannes Khinast
Johannes Khinast

1 August 2019 in Chemical Engineering Science
Verified
Journal Article
Closed access
JMJosip Matić
Josip Matić
AWAndreas Witschnigg
Andreas Witschnigg
MZMichaela Zagler
Michaela Zagler
SESimone Eder
Simone Eder
Johannes KhinastJohannes Khinast
Johannes Khinast

9 December 2022 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
JMJosip Matić
Josip Matić
MSMilica Stanković-Brandl
Milica Stanković-Brandl
HBHannes Bauer
Hannes Bauer
JLJessica Lovey
Jessica Lovey
SMSophie Martel
Sophie Martel
JKJohannes Khinast
Johannes Khinast

1 June 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
RBRamona Baumgartner
Ramona Baumgartner
JMJosip Matić
Josip Matić
SSSimone Schrank
Simone Schrank
SLStephan Laske
Stephan Laske
Johannes KhinastJohannes Khinast
Johannes Khinast
EREva Roblegg
Eva Roblegg

24 June 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MSMartin Spoerk
Martin Spoerk
IKIoannis Koutsamanis
Ioannis Koutsamanis
JMJosip Matić
Josip Matić
SESimone Eder
Simone Eder
CZCarolina Patricia Alva Zúñiga
Carolina Patricia Alva Zúñiga
APAmrit Paudel
Amrit Paudel
To avoid any type of cross-contamination, residue-free production equipment is of utmost importance in the pharmaceutical industry. The equipment cleaning for continuous processes such as hot melt extrusion (HME), which has recently gained popularity in pharmaceutical applications, necessitates extensive manual labour and costs. The present work tackles the HME cleaning issue by investigating two cleaning strategies following the extrusion of polymeric formulations of a hormonal drug and for a sustained release formulation of a poorly soluble drug. First, an in-line quantification by means of UV–Vis spectroscopy was successfully implemented to assess very low active pharmaceutical ingredient (API) concentrations in the extrudates during a cleaning procedure for the first time. Secondly, a novel in-situ solvent-based cleaning approach was developed and its usability was evaluated and compared to a polymer-based cleaning sequence. Comparing the in-line data to typical swab and rinse tests of the process equipment indicated that inaccessible parts of the equipment were still contaminated after the polymer-based cleaning procedure, although no API was detected in the extrudate. Nevertheless, the novel solvent-based cleaning approach proved to be suitable for removing API residue from the majority of problematic equipment parts and can potentially enable a full API cleaning-in-place of a pharmaceutical extruder for the first time.